BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10091741)

  • 1. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls.
    Fransson P; Widmark A
    Cancer; 1999 Feb; 85(3):678-88. PubMed ID: 10091741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group.
    Fransson P; Widmark A
    Cancer; 1996 Sep; 78(5):1066-78. PubMed ID: 8780545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controls.
    Fransson P; Widmark A
    Acta Oncol; 2007; 46(4):517-24. PubMed ID: 17497319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controls.
    Fransson P
    Acta Oncol; 2008; 47(5):852-61. PubMed ID: 17899451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.
    Hoffman RM; Gilliland FD; Penson DF; Stone SN; Hunt WC; Potosky AL
    Cancer; 2004 Nov; 101(9):2011-9. PubMed ID: 15452835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study.
    Mols F; Korfage IJ; Vingerhoets AJ; Kil PJ; Coebergh JW; Essink-Bot ML; van de Poll-Franse LV
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):30-8. PubMed ID: 18538503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: a prospective assessment of acute and late treatment toxicity.
    Wahlgren T; Nilsson S; Ryberg M; Lennernäs B; Brandberg Y
    Acta Oncol; 2005; 44(6):633-43. PubMed ID: 16165923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.
    Berg A; Lilleby W; Bruland OS; Fosså SD
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1074-83. PubMed ID: 17703896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
    Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
    Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.
    Crook J; Esche B; Futter N
    Urology; 1996 Mar; 47(3):387-94. PubMed ID: 8633407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary and sexual quality of life 1 year following robotic assisted laparoscopic radical prostatectomy.
    Shikanov SA; Eng MK; Bernstein AJ; Katz M; Zagaja GP; Shalhav AL; Zorn KC
    J Urol; 2008 Aug; 180(2):663-7. PubMed ID: 18554650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
    Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
    Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls.
    Fransson P; Widmark A
    Urol Oncol; 2011; 29(2):137-44. PubMed ID: 19272798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
    Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
    Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
    Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
    Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.